PDIA3 and breast cancer: 16F16 more active than PACMA-31 in decreasing cell attachment, spreading, F-actin and focal adhesion organization and cell migration; reduced cell-adhesive activity of ECM of HCC1937 cells treated with 16F16; decreased activity of CM of pdia3-null MEF to support breast cancer cell spreading and F-actin or migration